Targeting Adenosine Signalling in Knee Chondropathy: The Combined Action of Polydeoxyribonucleotide and Pulsed

Lorenzo Moretti1, Davide Bizzoca1,2, Alessandro Geronimo3

  • 1Orthopaedics Unit-UOSD Vertebral Surgery, AOU Consorziale Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy.

Insights

New therapies targeting adenosine A2 receptors, like polydeoxyribonucleotides (PDRN) injections and Pulsed Electromagnetic Fields (PEMF), show promise for knee chondropathy. These treatments offer significant regenerative and healing effects, reducing pain and improving function.

Area of Science:

  • Orthopedics and Regenerative Medicine
  • Biochemistry and Molecular Biology

Background:

  • Knee chondropathy is a prevalent age-related degenerative cartilage condition.
  • Adenosine A2 receptors play crucial roles in cellular protection and disease states.

Purpose of the Study:

  • To review the role and therapeutic modulation of adenosine A2A receptors in knee chondropathy.
  • To evaluate novel treatments targeting the adenosine pathway for knee cartilage degeneration.

Main Methods:

  • Systematic review of 60 scientific articles.
  • Analysis of studies on intra-articular polydeoxyribonucleotides (PDRN) and Pulsed Electromagnetic Fields (PEMF) therapy.

Main Results:

  • Intra-articular PDRN injections reduce pain and improve function by promoting anti-inflammatory effects, cell growth, collagen, and extracellular matrix production.
  • PEMF therapy is effective for early osteoarthritis, patellofemoral pain syndrome, SONK, and as post-operative support, reducing inflammation.

Conclusions:

  • Targeting the adenosine signal via PDRN and PEMF offers significant benefits for knee chondropathy compared to conventional treatments.
  • These therapies represent valuable additions to the management of knee chondropathy.

Related Concept Videos